0000920465-19-000183.txt : 20191223 0000920465-19-000183.hdr.sgml : 20191223 20191223160938 ACCESSION NUMBER: 0000920465-19-000183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191220 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAMSAY DAVID A CENTRAL INDEX KEY: 0001283292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 191306100 MAIL ADDRESS: STREET 1: HALOZYME THERAPEUTICS, INC. STREET 2: 11588 SORRENTO VALLEY ROAD, #17 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_157713535980757.xml FORM 4 X0306 4 2019-12-20 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001283292 RAMSAY DAVID A C/O LA JOLLA PHARMACEUTICAL COMPANY 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 3.93 2019-12-20 4 A 0 12000 0 A 2029-12-20 Common Stock 12000.0 12000 D 1. This option represents a right to purchase a total of 12,000 shares of the Issuer's Common Stock which shall be fully vested and exercisable on December 20, 2020. /s/ Ryan Murr, by power of attorney for David A. Ramsay 2019-12-23